The nation of Zimbabwe has declined a substantial American healthcare agreement worth 367 million US dollars (272 million pounds) over five years due to Washington's request for confidential biological samples.
This rejection became public after a official document from December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the deal was "unbalanced".
A government representative has since clarified that the United States was demanding access to biological samples for scientific study and commercial purposes but was not willing to guarantee the benefits from any future treatments.
"We are forced to start the challenging and unfortunate task of scaling back our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy noted the United States had donated over $1.9bn for health programmes to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has appealed for continued negotiations to reach a deal suitable to both sides so the country's critical HIV programme can be sustained.
Broader Background
Zimbabwe's decision comes after a similar situation in neighbouring Kenya, where a high court halted a related deal with the US after concerns were filed about the security of Kenyans' medical information.
Since resuming office recently, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).
The agency had managed assistance for the US government, but Trump claimed its expenditure was "wasteful" and his government was seeking direct bilateral deals to enhance transparency and accountability.
As per statements, Sixteen nations in Africa have to date signed similar health pacts, constituting over $18.3bn in committed funds.
Specifics of the Rejected Deal
The money for Zimbabwe was intended to supported "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this cooperation would have delivered significant advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children currently on HIV treatment through US-supported initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana maintained the arrangement was "unfair".
"The proposal required Zimbabwe to share its genetic material and health information over an extended period, without any corresponding promise of access to any scientific breakthroughs – such as new medicines or tests – that might result from that provided information," he stated.
"Effectively, our country would provide the raw materials for medical research without any certainty that the final treatments would be accessible to our citizens should a new health crisis emerge."
Sovereignty and Global Health
He also noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were undermining systems already established through the international health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme created to deal with future pandemics.
"This framework is intended to guarantee that when a nation contributes its information, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the funds to develop them."
Zimbabwe's reservations over the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We are open to ongoing dialogue with our US partners on how subsequent collaboration could be arranged in a manner that honours the sovereignty and dignity of both nations."
Medical Community Response
A leading public health body stated it recognised the official position, but recommended that negotiations need to persist since a large portion of the country's HIV programmes relied on international support.
"If specific concerns exist, such as those relating to information security or agreement terms, these can often be resolved via detailed discussion and mutually agreed protections," the group commented.
This impasse highlights the complex tensions between accepting vital international aid and protecting national sovereignty in an ever more interconnected world.